emixustat hydrochloride

DRUG2 trials

Sponsors

Kubota Vision Inc., Acucela Inc.

Conditions

Proliferative Diabetic Retinopathymacular atrophy Stargardt Disease

Phase 2

Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy

CompletedNCT02753400

Kubota Vision Inc.Proliferative Diabetic Retinopathy

Start: 2016-05-31End: 2017-12-31Updated: 2021-05-19

Phase 3

A Phase 3 Multicenter, Randomized, Double-Masked Study Comparing the Efficacy and Safety of Emixustat Hydrochloride with Placebo for the Treatment of Macular Atrophy Secondary to Stargardt Disease

Active, not recruitingNL-OMON53320

Acucela Inc.macular atrophy Stargardt Disease

Start: 2019-09-18Target: 6Updated: 2024-02-28

Related Papers

Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study

Graefe s Archive for Clinical and Experimental Ophthalmology2020-08-2716 citations